Hundreds of Alterations and Potential Drug Targets to Starve Tumors Identified
Monday, April 22, 2013
A massive study analyzing gene expression data from 22 tumor types has identified multiple metabolic expression changes associated with cancer.
UTSW Researchers Identify New Potential Target for Cancer Therapy
Monday, April 22, 2013
Researchers have found that alternative splicing – a process that allows a single gene to code for multiple proteins – appears to be a new potential target for anti-telomerase cancer therapy.
Covance Expands Singapore Central Laboratory
Friday, April 19, 2013
The expansion doubles genomics footprint, adds anatomic pathology and nutritional chemistry capabilities.
U.S. Army and Vermillion Sign Cooperative Research and Development Agreement
Friday, April 19, 2013
U.S. Army and Vermillion to assess health and economic benefits of OVA1 as a standard of care.
SCT Licenses Exclusive Rights to Clinical Cancer Stem Cell Program
Friday, April 19, 2013
Corporate refocusing mission completed.
Integromics Partners with CITRE and CEIT
Friday, April 19, 2013
Venture attracts EUR 2 million grant for ‘new frontier’ of data interpretation for drug development.
AmpliPhi Establishes Collaboration with Intrexon
Thursday, April 18, 2013
Combined expertise to create new generation of bacteriophage-based therapeutics for antibiotic resistant infections.
Debiopharm Group to Support Ascepion in the Development of Debio 1144
Thursday, April 18, 2013
Development of Debio 1144 for the treatment of Chinese cancer patients.
UVP is Now an Analytik Jena Company
Thursday, April 18, 2013
Acquisition allows Analytik Jena to strengthen its presence in the US market and expand its product portfolio.
|
|
|
|
|
|
